N-Cyclopentyl-2-(((2-(2-fluorophenyl)-5-methyloxazol-4-yl)methyl)sulfinyl)acetamide

Catalog No. :
ACRJOP818
CAS No. :
1015857-83-6
Molecular Formula :
C18H21FN2O3S
Molecular Weight :
364.44

IUPAC Name:N-cyclopentyl-2-(((2-(2-fluorophenyl)-5-methyloxazol-4-yl)methyl)sulfinyl)acetamide

N-Cyclopentyl-2-(((2-(2-fluorophenyl)-5-methyloxazol-4-yl)methyl)sulfinyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Cyclopentyl-2-(((2-(2-fluorophenyl)-5-methyloxazol-4-yl)methyl)sulfinyl)acetamide
IUPAC NameN-cyclopentyl-2-(((2-(2-fluorophenyl)-5-methyloxazol-4-yl)methyl)sulfinyl)acetamide
Molecular FormulaC18H21FN2O3S
Molecular Weight364.44
SMILESO=C(NC1CCCC1)CS(CC2=C(C)OC(C3=CC=CC=C3F)=N2)=O
InChI KeyRLYWBXKXIQGTNQ-UHFFFAOYSA-N
SynonymAcetamide, N-cyclopentyl-2-[[[2-(2-fluorophenyl)-5-methyl-4-oxazolyl]methyl]sulfinyl]-;WAY-332027;N-Cyclopentyl-2-(((2-(2-fluorophenyl)-5-methyloxazol-4-yl)methyl)sulfinyl)acetamide
CAS No.1015857-83-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACRJOP818 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRJOP818 route product structure diagram
    ACRJOP8181015857-83-6
Inquiry

2. ACRJOP818 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRJOP818 route product structure diagram
    ACRJOP8181015857-83-6
Inquiry

Comments (0)